<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03194347</url>
  </required_header>
  <id_info>
    <org_study_id>MAGynMA</org_study_id>
    <nct_id>NCT03194347</nct_id>
  </id_info>
  <brief_title>Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas</brief_title>
  <acronym>MAGynMA</acronym>
  <official_title>Clinical Value of Molecular Genetic Analyzes in Gynecological Malignomas</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Women's Hospital Tübingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Women's Hospital Tübingen</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the planned research project is to find out the clinical significance of molecular
      genetic analyzes in gynecological malignomas. In particular, it will be investigated how the
      knowledge of a molecular-genetic finding affects the therapeutic decision of the physician.
      Furthermore, genetic changes in the tumor tissue will be compared with the changes in CTCs,
      DTCs and cfDNA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 29, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 29, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Influence of molecular genetic findings to the therapy decision</measure>
    <time_frame>3years</time_frame>
    <description>It will be analyzed if the physicians selection of a therapy is influenced by a present molecular genetic finding. Therapy recommondation based on molecular genetic analysis will be compared with the acutal therapy decision.</description>
  </primary_outcome>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Gynecologic Cancer</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>molecular genetic analyses</intervention_name>
    <description>molecular genetic analyses</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All patients with a gynecological malignancy, in whom a genetic testing of tumor tissue
        (somatic mutation) and blood cells (germ line mutation) has already taken place.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a solid tumor disease

          -  The presence of a molecular genetic diagnosis of the tumor tissue from practice for
             human genetics

          -  Age &gt; 18 years

          -  informed consent

        Exclusion Criteria:

          -  life expectancy &lt;12 months or worse general condition (Karnofsky &lt;70)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>gynecological tumors</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas D Hartkopf, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Women's Health</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andreas D Hartkopf, Prof</last_name>
    <phone>0049 7071 29 86299</phone>
    <email>andreas.hartkopf@med.uni-tuebingen.de</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Women's Hospital</name>
      <address>
        <city>Tübingen</city>
        <zip>72076</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas D Hartkopf, Prof</last_name>
      <phone>0049 7071 29 86299</phone>
      <email>andreas.hartkopf@med.uni-tuebingen.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 22, 2017</study_first_submitted>
  <study_first_submitted_qc>June 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 21, 2017</study_first_posted>
  <last_update_submitted>June 23, 2017</last_update_submitted>
  <last_update_submitted_qc>June 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

